Passage Bio, a new start-up cofounded by University of Pennsylvania professor James Wilson, has raised $115.5 million in series A financing to develop gene therapies for rare genetic diseases of the ...

Passage Bio, a gene therapy start-up cofounded by University of Pennsylvania scientist James Wilson (see page 32), has raised $110 million in series B financing from over 10 venture capital firms.

Clinical setbacks and controversial pricing may have put a dampener on the gene therapy sector, but one of the industry’s pioneers is looking for a way forward. GEMMA Biotherapeutics, the biotech ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The one-time postdoctoral ...

Dr. James Wilson is a pioneer in gene therapy. That does not mean he is necessarily impressed with the current state of affairs. “In five years, when we look back on the way we’re executing on gene ...

Despite signing both the Declaration of Independence and the Constitution and being one of six original justices appointed to the Supreme Court, James Wilson is not often thought of as a leading light ...